Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Get Alerts RCUS Hot Sheet
Join SI Premium – FREE
HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer and inflammatory and autoimmune diseases, announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs Global Healthcare Conference in Miami Beach, FL. The fireside chat will take place on Tuesday, June 9th, 2026, at 10:40am ET.
A live webcast of the presentation will be available by visiting the “Investors & Media” section of the Arcus Biosciences website at www.arcusbio.com. A replay will be available following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for the treatment of cancer and inflammatory and autoimmune diseases. In partnership with industry collaborators, patients and physicians around the world, Arcus is expediting the development of its late-stage portfolio of first- and/or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has advanced multiple investigational medicines into registrational clinical trials including casdatifan, a HIF-2a inhibitor for clear cell renal cell carcinoma, and quemliclustat, a small-molecule CD73 inhibitor for pancreatic cancer. For more information about Arcus Biosciences’ clinical and preclinical programs, please visit www.arcusbio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260526060565/en/
Investor & Media Inquiries
Holli Kolkey
VP of Corporate Affairs
(650) 922-1269
[email protected]
Maryam Bassiri
Director, Corporate Affairs
(510) 406-8520
[email protected]
Source: Arcus Biosciences
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Angle Health Announces Next Series of Fireside Chats Focused on Smarter, More Sustainable Health Benefits Strategies
- Proofpoint Joins the OpenAI Daybreak Cyber Partner Program to Advance Responsible AI-Powered Cyber Defense
- FE International Advises on the Acquisition of Clubmate by FishPal
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share